The evolution of antifungal therapy: Traditional agents, current challenges and future perspectives

被引:1
作者
de Souza, Cassia Milena [1 ]
Bezerra, Barbara Tavares [1 ]
Mellon, Daniel Agreda [1 ,2 ]
de Oliveira, Haroldo Cesar [1 ,3 ]
机构
[1] Fundacao Oswaldo Cruz Fiocruz, Inst Carlos Chagas, Curitiba, PR, Brazil
[2] Fundacao Oswaldo Cruz Fiocruz, Programa Posgrad Biol Parasitaria, Inst Oswaldo Cruz, Rio De Janeiro, Brazil
[3] Fed Univ Sao Paulo UNIFESP, Dept Microbiol Immunol & Parasitol, Discipline Cellular Biol, Sao Paulo, Brazil
来源
CURRENT RESEARCH IN MICROBIAL SCIENCES | 2025年 / 8卷
关键词
Antifungal therapy; Antifungal drugs; Antifungal drug development; IN-VITRO ACTIVITY; SEROTONIN REUPTAKE INHIBITORS; AMPHOTERICIN-B; FLUCONAZOLE RESISTANCE; COMBINATION THERAPY; SILVER NANOPARTICLES; REZAFUNGIN CD101; ASPERGILLUS SPP; DRUG-RESISTANCE; CANDIDA;
D O I
10.1016/j.crmicr.2025.100341
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Fungal infections kill more than 3 million people every year. This high number reflects the significant challenges that treating these diseases worldwide presents. The current arsenal of antifungal drugs is limited and often accompanied by high toxicity to patients, elevated treatment costs, increased frequency of resistance rates, and the emergence of naturally resistant species. These treatment challenges highlight the urgency of developing new antifungal therapies, which could positively impact millions of lives each year globally. Our review offers an overview of the antifungal drugs currently available for treatment, presents the status of new antifungal drugs under clinical study, and explores ahead to future candidates that aim to help address this important global health issue.
引用
收藏
页数:20
相关论文
共 297 条
[1]   Therapeutic Potential of Green Synthesized Gold Nanoparticles Using Extract of Leptadenia hastata against Invasive Pulmonary Aspergillosis [J].
Abdallah, Basem M. ;
Ali, Enas M. .
JOURNAL OF FUNGI, 2022, 8 (05)
[2]   Fabrication and optimization of itraconazole-loaded zein-based nanoparticles in coated capsules as a promising colon-targeting approach pursuing opportunistic fungal infections [J].
Adel, Shery ;
Fahmy, Rania H. ;
Elsayed, Ibrahim ;
Mohamed, Magdy I. ;
Ibrahim, Reem R. .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2023, 13 (12) :2982-3002
[3]   Amphotericin B lipid preparations: what are the differences? [J].
Adler-Moore, J. P. ;
Proffitt, R. T. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 :25-36
[4]   Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached? [J].
Aigner, Maria ;
Lass-Floerl, Cornelia .
JOURNAL OF FUNGI, 2020, 6 (02)
[5]   Secreted Aspartyl Proteinases Targeted Multi-Epitope Vaccine Design for Candida dubliniensis Using Immunoinformatics [J].
Akhtar, Nahid ;
Magdaleno, Jorge Samuel Leon ;
Ranjan, Suryakant ;
Wani, Atif Khurshid ;
Grewal, Ravneet Kaur ;
Oliva, Romina ;
Shaikh, Abdul Rajjak ;
Cavallo, Luigi ;
Chawla, Mohit .
VACCINES, 2023, 11 (02)
[6]   In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains [J].
Aldejohann, Alexander Maximilian ;
Menner, Carolina ;
Thielemann, Nadja ;
Martin, Ronny ;
Walther, Grit ;
Kurzai, Oliver .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (02)
[7]  
Alexander B.D., 2020, Open Forum Infect. Dis, V7, DOI [10.1093/ofid/ofaa439.1432. S642-S642, DOI 10.1093/OFID/OFAA439.1432.S642-S642]
[8]   Novel combinatorial approach: Harnessing HIV protease inhibitors to enhance amphotericin B's antifungal efficacy in cryptococcosis [J].
Alkashef, Nour M. ;
Seleem, Mohamed N. .
PLOS ONE, 2024, 19 (08)
[9]   Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis [J].
Alkhazraji, Sondus ;
Gebremariam, Teclegiorgis ;
Alqarihi, Abdullah ;
Gu, Yiyou ;
Mamouei, Zeinab ;
Singh, Shakti ;
Wiederhold, Nathan P. ;
Shaw, Karen J. ;
Ibrahim, Ashraf S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
[10]   Fosmanogepix: The Novel Anti-Fungal Agent's Comprehensive Review of in Vitro, in Vivo, and Current Insights From Advancing Clinical Trials [J].
Almajid, Ali ;
Bazroon, Ali ;
Al-awami, Hashim M. ;
Albarbari, Hassan ;
Alqahtani, Ibrahim ;
Almutairi, Rehab ;
Alsuwayj, Abbas ;
Alahmadi, Faiza ;
Aljawad, Jinan ;
Alnimer, Razan ;
Asiri, Nawal ;
Alajlani, Shouq ;
Alshelali, Reem ;
Aljishi, Yamama .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)